With 29 new infections, the DRC outbreak has grown to 53 cases and 31 deaths.
Senegal announced today the country's first Ebola virus disease case, in a student from Guinea who was located in a Dakar hospital.
The National Institutes of Health (NIH) has partnered with an international-based consortium based in Britain to fast-forward work on an Ebola virus vaccine developed by GSK that has shown promise in nonhuman primate studies.
With an estimated price tag of $490 million, the plan's goal is to stop Ebola transmission in 6 to 9 months.
In addition, Canada pulled a lab team from Sierra Leone.
The US government plans to request that federally funded laboratories suspend all work on potentially dangerous pathogens for about 24 hours to inventory stocks of microbes, ScienceInsider reported today.
The first patient in the DRC's Ebola outbreak caught the virus from a dead animal, making any link to West Africa's outbreak unlikely.
The WHO sent a team to a hot spot where one of its Ebola workers was infected.
The US Centers for Disease Control and Prevention (CDC) yesterday released guidance for handling the bodies of patients who die from Ebola infections. The advice is aimed at those performing postmortem care in US hospitals and mortuaries.
The WHO has heightened concerns about the impact the outbreak is having on frontline workers and the prospects of overseas help.
